Covid 19
Covid 19
Select a category:
INNOVA SARS-CoV-2 Rapid Antigen Lateral Flow Test Kit x25
Product Code: INNOVA SARS-CoV-2 Rapid Antigen Lateral Flow Test Kit x25
The Rapid COVID-19 Innova Antigen Test is an in vitro immunochromatographic assay for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in direct nose and/or throat swab from individuals who are suspected of COVID-19 by their healthcare provider.
Out of Stock - Coming Soon
Healgen COVID-19 Rapid Antigen Test x20
Product Code: Healgen COVID-19 Rapid Antigen Test x20
This swab test is intended for the rapid detection of COVID-19 - results available within 15 minutes with high accuracy.
- Each kit contains everything required to carry out the tests- no additional equipment is needed.
- Approved by Public Health England & validated by the UK Government.
- Results in 15 minutes.
- Each kit includes clear instructions and is easy to use.
Out of Stock - Coming Soon
Gensure Covid 19 Rapid Anti Gen Test x20
Product Code: Gensure Covid 19 Rapid Anti Gen Test x20
The GenSureTM COVID-19 Antigen Rapid Test Kit is a polymer immunochromatographic technology and double antibody sandwich principle that is intended for the qualitative detection of the N protein antigen from SARS-CoV-2 in human nasal swab specimens directly.
Results in as little as 15 minute's.
Reductions on bulk orders, email sales@lawmedicalsupplies.co.uk for information
Coronavirus Antigen Rapid Test Kit x20
Product Code: Coronavirus Antigen Rapid Test Kit x20
JOYSBIO’s coronavirus Ag test kit was independently evaluated at Centro Diagnostico Delta S.r.l. in Italy between October 2020 and January 2021. A total of 107 positive specimens were tested with JOYSBIO’s COVID-19 Antigen Rapid Test Kit. These specimens were collected from patients who are suspected of COVID-19 with nasal swabs. The coronavirus antigen test kit’s sensitivity and specificity are compared against a CE-IVD marked RT-PCR test kit. This clinical evaluation is conducted under the assumption that SARS-CoV is no longer spreading in the community.
According to the clinical analysis of 492 samples, the detection sensitivity is 98.13%, and the specificity is 99.22%.